Table 1. Clinicopathologic factors related to BRAF mutation in 1,199 patients with PTC.
Clinicopathologic factors | BRAF (+) | BRAF (−) | χ2/t-test | P | Spearman | P |
---|---|---|---|---|---|---|
Age (years) | 791 | 408 | 0.608 | 0.436 | 0.099 | 0.001 |
Mean ± SD | 43.8±12.0 | 46.7±13.0 | <0.001 | |||
≤45 | 433 | 180 | ||||
>45 | 358 | 228 | ||||
Sex | 791 | 408 | 268.1 | <0.001 | −0.052 | 0.074 |
Male | 195 | 121 | ||||
Female | 596 | 287 | ||||
Tumor size (cm) | 888 | 427 | 22.2 | <0.001 | 0.031 | 0.264 |
Mean ± SD | 0.82±0.49 | 0.86±0.56 | <0.001 | |||
<1.0 | 688 | 320 | ||||
≥1.0 | 200 | 107 | ||||
Multiplicity | 134.7 | <0.001 | 0.040 | 0.151 | ||
Absent | 884 | 427 | ||||
Present | 4 | 0 | ||||
Bilaterality | 158.2 | <0.001 | 0.108 | 0.001 | ||
Absent | 791 | 408 | ||||
Present | 97 | 19 |
PTC, papillary thyroid carcinoma.